Safe prescription of systemic antineoplastic treatment in oncology: integrative literature review

Safe prescription of systemic antineoplastic treatment in oncology: integrative literature review

The objective of this study was to identify the available evidence on the parameters that should be considered to improve the quality and safety of the prescription of systemic antineoplastic treatment. This is an integrative review carried out in the EMBASE, LILACS, and PubMed databases, from 2015...

Full description

Bibliographic Details
Main Authors:	Fabiola Vasconcelos Alves, Renata Cristina de Campos Pereira Silveira, Flavia Oliveira de Almeida Marques da Cruz, Elaine Barros Ferreira, Paula Elaine Diniz dos Reis
Format:	Article
Language:	English
Published:	Sociedade Brasileira de Oncologia Clínica, Sociedade Brasileira de Cirurgia Clínica and Sociedade Brasileira de Radioterapia 2022-10-01
Series:	Brazilian Journal of Oncology
Subjects:	antineoplastic agents immunotherapy drug-related side effects and adverse reactions patient safety
Online Access:	https://www.brazilianjournalofoncology.com.br/details/187/en-US/safe-prescription-of-systemic-antineoplastic-treatment-in-oncology--integrative-literature-review

Similar Items

Safe Handling of Antineoplastic Drugs in Oncology Nursing
by: Rujnan Tuna
Published: (2014-12-01)

Ocular complications of antineoplastic therapies
by: Abbas Bader, et al.
Published: (2023-08-01)

Ashgate handbook of antineoplastic agents /
by: Milne, George W. A., 1937-
Published: (2000)

Incidence, characteristics, and clinical impact of serious adverse events in patients with breast cancer receiving antineoplastic treatment in the ambulatory setting
by: Zahieh AbuAloush, et al.
Published: (2024-12-01)

SATISFACTION WITH NURSING CARE OF ONCOLOGY PATIENTS ON OUTPATIENT ANTINEOPLASTIC DRUGS
by: Jean Vitor Silva Ferreira, et al.
Published: (2023-08-01)

Antineoplastics Encapsulated in Nanostructured Lipid Carriers
by: Gustavo Henrique Rodrigues da Silva, et al.
Published: (2021-11-01)

Melatonin’s Antineoplastic Potential Against Glioblastoma
by: Enrico Moretti, et al.
Published: (2020-03-01)

Effects of safe handling education on cognition, compliance and stress handling of antineoplastic drugs in clinical nurses
by: Eun‐Mi Jun, et al.
Published: (2023-06-01)

Medication guide for dose adjustment and management of cardiotoxicity and lipid metabolic adverse events of oral antineoplastic therapy
by: Elena Ramos-Ruperez, et al.
Published: (2023-08-01)

Evaluation of the Impact of Implementing Electronic Prescription in an Oncology Referral Hospital in Recife, Brazil
by: Diana Carla Gouveia Falcão, et al.
Published: (2025-01-01)

Recommendations by the Spanish Society of Hospital Pharmacy, the Spanish Society of Oncology Nursing and the Spanish Society of Medical Oncology for the safe management of antineoplastic medication in cancer patients
by: María José Otero, et al.
Published: (2018-11-01)

Osteometabolic changes in patients under antineoplastic treatment: scoping review
by: Lucas Dalvi Armond Rezende, et al.
Published: (2023-09-01)

Safe practices for prevention and management of antineoplastic agent extravasation: development of an educational video
by: Rafael Fernando Mendes Barbosa, et al.
Published: (2024-11-01)

Antineoplastic drugs-related medication-associated pseudoporphyria
by: Philip R. Cohen, MD
Published: (2023-12-01)

Antineoplastic agents associated with the development of drug-induced pancreatitis
by: N. A. Arablinskiy, et al.
Published: (2021-08-01)

Implementation of a robot for the preparation of antineoplastic drugs in the Pharmacy Service
by: María de la Paz Pacheco Ramos, et al.
Published: (2015-01-01)

The application of Global Trigger Tool in monitoring antineoplastic adverse drug events: a retrospective study
by: Yang Liu, et al.
Published: (2024-05-01)

Performance Qualification of Automatic System for Antineoplastic Preparation
by: Giuseppe Tesse, et al.
Published: (2023-12-01)

Biopolymeric Prodrug Systems as Potential Antineoplastic Therapy
by: Adriana Aurelia Chis, et al.
Published: (2022-08-01)

Complementary medicine use in cancer patients receiving intravenous antineoplastic treatment
by: Regina Juanbeltz Zurbano, et al.
Published: (2017-09-01)

Cost-effectiveness study of closed system transfer devices for the preparation of antineoplastic agents
by: Gloria Calzado-Gómez, et al.
Published: (2017-09-01)

Applying dose banding to the production of antineoplastic drugs: a narrative review of the literature
by: Pablo Pérez Huertas, et al.
Published: (2015-07-01)

Evaluation of potential drug interactions in hospitalized pediatric oncology patients
by: Emanuella de Souza Ribeiro, et al.
Published: (2021-02-01)

Nuclear Receptors and Stress Response Pathways Associated with the Development of Oral Mucositis Induced by Antineoplastic Agents
by: Moena Kagaya, et al.
Published: (2024-08-01)

Shanghai expert consensus on whole-process management of antineoplastic-induced nausea and vomiting (2024 edition)
by: Cancer Rehabilitation and Palliative Professional Committee of Shanghai Anti-Cancer Association , Cancer Drug Clinical Research Committee of Shanghai Anti-Cancer Association , Cancer Prevention and Clinical Research Committee of Chinese Aging Well Association
Published: (2024-01-01)

Recent development of micro-nano carriers for oral antineoplastic drug delivery
by: Hongzheng Li, et al.
Published: (2025-02-01)

Chemotherapy: some potential risks under antineoplastic drugs handling
by: L. G. Solenova, et al.
Published: (2017-10-01)

Strategic Improvement of Oral Antineoplastic Investigational Agents Compliance
by: Anas Alshawa, et al.
Published: (2019-02-01)

Prévalence et gestion des effets indésirables notifiés suite à l’utilisation de bévacizumab dans la prise en charge des cancéreux à l’EPH de Chlef
by: Derouicha Matmour, et al.
Published: (2024-07-01)

Occupational Exposure to Antineoplastic Drugs: Identification of Job Categories Potentially Exposed throughout the Hospital Medication System
by: Chun-Yip Hon, et al.
Published: (2011-09-01)

Heart protective effects of cardioactive drugs associated with antineoplastic treatment against breast cancer
by: Tatiana Fonseca, et al.
Published: (2022-10-01)

Incidence of immunotherapy‐related hyperprogressive disease (HPD) across HPD definitions and cancer types in observational studies: A systematic review and meta‐analysis
by: Min Jeong Kim, et al.
Published: (2024-02-01)

Evaluation of Different Wipes’ Performance for Sampling the Antineoplastic Drug 5-Fluorouracil from Various Surfaces
by: Zahra Beigzadeh, et al.
Published: (2024-10-01)

Identification of Knowledge Gaps Regarding Healthcare Workers' Exposure to Antineoplastic Drugs: Review of Literature, North America versus Europe
by: Chun-Yip Hon, et al.
Published: (2014-12-01)

First use of antineoplastic agents in women with breast cancer in the state of Rio de Janeiro, Brazil
by: Ranailla Lima Bandeira dos Santos, et al.
Published: (2023-02-01)

Studies on anticancer principles in Chinese medicines : II. Cytotoxic principles in Biota orientalis(L.) ENDL. and Kaempferia galanga L /
by: Takuo, Kosuge

The Chemistry of antitumour agents /
by: Wilman, Derry E. V.
Published: (1990)

Anti-tumor effect of metformin in oncological patients: a systematic review
by: Rafaela Korb de Oliveira, et al.
Published: (2024-12-01)

Application of a multifunctional chemotherapy infusion device for reducing antineoplastic drug extravasation
by: Li-Hua Yang, et al.
Published: (2025-03-01)

Use of a Zebrafish Model to Evaluate Toxicity of Schiff Base Complexes of Copper (II) and Zinc (II) as Possible Antineoplastic Agents
by: Claudia Cardozo, et al.
Published: (2019-08-01)